Biomarkers for the Detection and Surveillance of Renal Cancer. The Urologic clinics of North America Nolazco, J. I., Soerensen, S. J., Chung, B. I. 2023; 50 (2): 191-204


Renal cell carcinoma (RCC) is a heterogeneous disease characterized by a broad spectrum of disorders in terms of genetics, molecular and clinical characteristics. There is an urgent need for noninvasive tools to stratify and select patients for treatment accurately. In this review, we analyze serum, urinary, and imaging biomarkers that have the potential to detect malignant tumors in patients with RCC. We discuss the characteristics of these numerous biomarkers and their ability to be used routinely in clinical practice. The development of biomarkers continues to evolve with promising prospects.

View details for DOI 10.1016/j.ucl.2023.01.009

View details for PubMedID 36948666